ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring KRASG12C Mutations"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring KRASG12C Mutations"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Tony Mok

218 views

June 13, 2024

0 Comments

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

2024 ASCO® Annual Meeting Insights Hub: Lung Videos

19:33

ecancer

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

Feat. E. Felip, A. Spira, A. Passaro, A. Addeo

16:10

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOM…

Feat. L. Raez

36:14

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

Feat. B. Halmos

View All

The Use of IO Doublet in PD-L1-Negative NSCLC

35:40

Balazs Halmos

Year in Review: Lung Cancer

57:44

Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl

17:20

Total Health

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Feat. J. Porter

18:47

Total Health

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Feat. W. Iams

27:04

Fengting Yan

Cancer Screening Molecular Tools

17:50

AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde

11:07

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical…

Feat. J. West

07:43

Yale Cancer Center

2024 Updates on NSCLC Targeted Therapies: FLAURA2 Trial - Osimertini…

Feat. P. Janne

25:35

Total Health

NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing

Feat. S. Kazmi

17:34

ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

Feat. L. Raez

29:25

Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

14:49

Vivek Subbiah

Year in Review: Precision Medicine

13:19

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

Feat. E. Rodriguez

26:21

Memorial Sloan Kettering Cancer Center

NSCLC & Targeted Therapy: A Brief Overview and Update in the Met…

Feat. M. Hwang

16:10

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOM…

Feat. L. Raez

06:47

UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang

16:12

Total Health

2024 Updates on the Fast-Changing NSCLC Landscape

Feat. R. Osarogiagbon

20:52

Total Health

Diagnostics in Lung Cancer: A Comprehensive Discussion - Best of Lun…

Feat. T. Boyle

21:24

Chul Kim

Login

Login

Join VuMedi

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring KRASG12C Mutations"

2024 ASCO® Annual Meeting Insights Hub: Lung Videos

Related Content